Factor Therapeutics (FTT) Stock Price, News & Analysis

Company Overview

Factor Therapeutics Limited operates as a biotechnology company that focuses on developing and commercializing advanced wound care therapies. The company was formerly known as Tissue Therapies Limited and changed its name to Factor Therapeutics Limited in May 2016. Factor Therapeutics Limited was incorporated in 2002 and is based in Brisbane, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 425,600 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

FTT Stock Analysis - Frequently Asked Questions

How were Factor Therapeutics' earnings last quarter?

Factor Therapeutics Limited (ASX:FTT) released its quarterly earnings results on Thursday, August, 8th. The biotechnology company reported $0.00 earnings per share (EPS) for the quarter.

Company Calendar

• Last Earnings: 8/08/2019
• Today: 9/08/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: ASX:FTT
• Previous Symbol: ASX:TIS
• CIK: N/A
• Web: factor-therapeutics.com
• Phone: +61-7-33343900
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 19.84
• Quick Ratio: 19.76

Sales & Book Value

• Annual Sales: A$1.79 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 1.00
• Book Value: A$0.03 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 104,284,000
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A